title: Experimental and numerical studies of adenovirus delivery to outflow tissues of perfused human anterior segments.
abstract: OBJECTIVE
  To investigate the efficacy of two different methods of adenoviral transfer of genes to trabecular meshwork (TM) and Schlemm's canal (SC) cells in cultured human anterior segments, using both experimental and numerical analyses.
  
  
  METHODS
  Replication-deficient adenoviruses having coding sequence for beta-galactosidase (beta-gal) under the control of the cytomegalovirus promoter were used. Efficiency of gene transfer over time was verified by infecting cultured human TM cells and assaying for beta-gal activity. Next, ostensibly normal paired human eyes were prepared by standard techniques and perfused for 2 to 5 days to measure baseline facilities. Eyes were then infected by one of two methods: standard transcorneal puncture, or injection into a 1 mm diameter silastic segment of supply tubing immediately upstream of the perfusion dish. In both cases, the nominal total dose was 2 x 10(8) viral particles. Five days after viral injection, eyes were harvested and fixed, and wedges from each of four quadrants were examined histologically. Sections were assayed for beta-gal activity and/or stained with toluidine blue. In a parallel study, flow and viral transport within perfused anterior segments were numerically simulated for conditions that approximated those used experimentally.
  
  
  RESULTS
  Eyes receiving viral particles by transcorneal injection showed variable levels of beta-gal activity and highly variable TM cellular morphology, ranging from excellent preservation to cellular lysis. Eyes receiving an equivalent viral dose via the supply tubing showed higher transfer efficiency, as judged by almost complete TM cell loss (indicative of viral toxicity) and intense extracellular beta-gal activity from the residual cytoplasm. At lower doses (1/3 to 1/1000 of that used in transcorneal injection) beta-gal activity was still present, while TM cell morphology was good at the lower viral doses. Computer modeling showed that the region beneath the cornea was nearly stagnant, and consequently virus introduced into this region by transcorneal injection was delivered very slowly to the TM. This caused the effective delivered viral dose to be low and sensitively dependent on the volume and shape of the transcorneally injected virus bolus.
  
  
  CONCLUSIONS
  Injection of adenovirus into supply tubing led to consistent delivery of reporter gene and approximately 300-fold greater efficiency of gene transfer compared to the transcorneal injection method, and is therefore the preferred method for introducing viral particles into perfused anterior segments. These findings were consistent with computer modeling of flow and mass transport in perfused anterior segments. Although these quantitative results are specific to adenovirus, this general trend should hold for a wide range of perfused compounds.
authors.affiliation: Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Ontario, Canada. ethier@mie.utoronto.ca
authors.forename: C Ross
authors.initials: CR
authors.lastname: Ethier
authors.forename: Shigeo
authors.initials: S
authors.lastname: Wada
authors.forename: Darren
authors.initials: D
authors.lastname: Chan
authors.forename: W Daniel
authors.initials: WD
authors.lastname: Stamer
mesh_terms: D000260:Adenoviruses, Human / Q000235:genetics*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000869:Anterior Eye Segment / Q000201:enzymology / Q000473:pathology / Q000821:virology; D003198:Computer Simulation; D003673:Defective Viruses; D005260:Female; D015971:Gene Expression Regulation, Enzymologic / Q000502:physiology; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D009924:Organ Culture Techniques; D014129:Trabecular Meshwork / Q000201:enzymology* / Q000473:pathology / Q000821:virology; D001616:beta-Galactosidase / Q000235:genetics* / Q000378:metabolism
chemical_list: D001616:beta-Galactosidase